Requesting Appropriate Interpreters Clause Samples

Requesting Appropriate Interpreters. (1) The Authorized Requester is encouraged to take the following factors into consideration when evaluating the suitability of a particular interpreter for a particular appointment; (a) Communication style and preference for the customer(s); (b) Number of the Deaf, Hard of Hearing, Deaf-Blind Customer(s) involved in the appointment; (c) Nature of the Appointment, and Interpreter’s knowledge and experience in similar settings; (d) Any circumstances which might affect (or appear to affect) the interpreter’s objectivity, including but not limited, to conflict of interest and prior personal relationship and/or business dealings with parties involved in the appointment. (2) The Authorized Requester and Contractor must make diligent effort to use the customer’s preferred interpreters. Where that option is not available, the Contractor shall appropriately match the Interpreter’s experience, a skill with the Customer’s preferred communication. (3) The Authorized Requester and Contractor must not use Family Members or Interpreters not approved by ODHH to provide services under this contract. (4) The Contractor must check the availability of the requested Interpreter(s), as indicated on DSHS form 17-123a Request for Sign Language Interpreter (▇▇▇▇://▇▇▇.▇▇▇▇.▇▇.▇▇▇/pdf/ms/forms/17_123a.pdf). If the specific Interpreter(s) requested is unavailable, the Contractor must inform the Requester. (5) The Requester reserves the right to reject any or all of the Interpreters selected by the Contractor as unacceptable within 24 hours of receiving the information.
View SourceView Similar (27)
Requesting Appropriate Interpreters. (1) The Requester must consult with the Customer on his/her communication needs and come to an agreement on his/her Interpreter preferences. The expressed needs and preferences shall be indicated on DSHS form 17-123a Request for Sign Language Interpreter. (2) Authorized Requesters requesting Interpreter services through this contract reserve the right to determine if the Interpreter(s) meet the needs of any Appointment. This determination will be based on review of many factors, including, but not limited to: (a) Number of the deaf, hard of hearing, deaf-blind Customer(s); (b) Expressed communication needs & preferences of the Customer(s); (c) Length of the Appointment; (d) Type/setting of Appointment; (e) Certification level of Interpreters. (3) The Requester and Contractor must make diligent effort to appropriately match the Interpreter’s certification, experience, and preferences with the Customer’s preferred communication needs, Appointment setting, and other information as indicated on DSHS form 17-123a Request for Sign Language Interpreter. The Requester/Contractor must not use Family Members or Interpreters not approved by ODHH to provide Interpreter services under this contract. (4) To assign appropriate Interpreters for Appointments, the Authorized Requester and Contractor shall use ODHH “Guidelines – Matching Qualified Interpreter with Appointment Setting” to match the Interpreter’s certification with the Customer’s preferred communication needs and Appointment setting. (5) The Contractor must check the requested Interpreter(s) availability, as indicated on DSHS form 17-123a Request for Sign Language Interpreter. If the specific Interpreter(s) requested is unavailable, the Contractor must inform the Requester of the Interpreter(s)’s unavailability. (6) The Requester reserves the right to reject any or all of the Interpreters selected by the Contractor as unacceptable.
View SourceView Similar (2)
Requesting Appropriate Interpreters. (1) The Requester must consult with the Customer on his/her communication needs and come to an agreement on his/her Interpreter preferences. The expressed needs and preferences shall be indicated on DSHS form 17-123a Request for Sign Language Interpreter. (2) Authorized Requesters requesting Interpreter services through this contract reserve the right to determine if the Interpreter(s) meet the needs of any Appointment. This determination will be based on review of many factors, including, but not limited to: (a) Number of the Deaf, Hard of Hearing, Deaf-Blind Customer(s); (b) Expressed communication needs & preferences of the Customer(s); (c) Length of the Appointment; (d) Type/setting of Appointment;
View Source

Related to Requesting Appropriate Interpreters

  • Regulatory Applications (a) Summit and GAFC and their respective Subsidiaries shall cooperate and use their respective reasonable best efforts to prepare all documentation, to effect all filings and to obtain all permits, consents, approvals and authorizations of all third parties and Governmental Authorities necessary to consummate the transactions contemplated by this Agreement. Each of Summit and GAFC shall have the right to review in advance, and to the extent practicable each will consult with the other, in each case subject to applicable laws relating to the exchange of information, with respect to, all material written information submitted to any third party or any Governmental Authority in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each of the parties hereto agrees to act reasonably and as promptly as practicable. Each party hereto agrees that it will consult with the other party hereto with respect to the obtaining of all material permits, consents, approvals and authorizations of all third parties and Governmental Authorities necessary or advisable to consummate the transactions contemplated by this Agreement and each party will keep the other party apprised of the status of material matters relating to completion of the transactions contemplated hereby. (b) Each party agrees, upon request, to furnish the other party with all information concerning itself, its Subsidiaries, directors, officers and stockholders and such other matters as may be reasonably necessary or advisable in connection with any filing, notice or application made by or on behalf of such other party or any of its Subsidiaries to any third party or Governmental Authority.

  • Consistent Application The Employer agrees that management rights will not be exercised in a manner inconsistent with the express provisions of this Agreement.

  • Third Party Applications Oracle or third party providers may offer Third Party Applications. Except as expressly set forth in the Estimate/Order Form, Oracle does not warrant any such Third Party Applications, regardless of whether or not such Third Party Applications are provided by a third party that is a member of an Oracle partner program or otherwise designated by Oracle as “Built For NetSuite,” "certified," "approved" or “recommended.” Any procurement by Customer of such Third Party Applications or services is solely between Customer and the applicable third party provider. Customer may not use Third Party Applications to enter and/or submit transactions to be processed and/or stored in the Cloud Service, unless Customer has procured the applicable subscription to the Cloud Service for such use and access.

  • Listing Application If shares of any class of stock of the Company shall be listed on a national securities exchange, the Company shall, at its expense, include in its listing application all of the shares of the listed class then owned by any Investor.

  • Regulatory Materials (a) On a Program-by-Program basis, commencing on the Effective Date until the Regulatory Transfer Date, Prothena shall have the right, in consultation with Celgene, to prepare, file and maintain all Regulatory Materials (including any Regulatory Approvals) necessary for the Development and Manufacture of any Collaboration Candidates and Collaboration Products for such Program (collectively, the “Program Regulatory Materials”), and to interact with Regulatory Authorities in connection with the Development and Manufacture of any Collaboration Candidates and Collaboration Products for such Program. Prothena will provide Celgene with a reasonable opportunity to comment substantively on all material Regulatory Materials prior to filing or taking material action, and will reasonably and in good faith consider any comments and actions recommended by Celgene, including with respect to filing strategy. In addition, Prothena will allow Celgene or its representative to attend any and all meetings with Regulatory Authorities to the extent such attendance is not prohibited or limited by such Regulatory Authority. (b) If Celgene exercises its Phase 1 Portion Participation Right for a given Program, then immediately after such exercise, Prothena shall initiate the transfer of all Program Regulatory Materials, including for clarity any IND for the relevant Collaboration Candidates and/or Collaboration Products that are the subject of such Program to Celgene. The date on which such Program Regulatory Materials are transferred to Celgene shall be the “Regulatory Transfer Date” for such Program. Thereafter, Celgene shall have the right, in consultation with Prothena, to prepare, file, and maintain such Program Regulatory Materials, and to interact with Regulatory Authorities in connection with the Development and, as applicable, Manufacture of such Collaboration Candidates and Collaboration Products for such Program in accordance with the terms and conditions of Section 2.5. Additionally, with respect to any Phase 1 Clinical Trial conducted by Celgene pursuant to Section 2.5, Celgene will provide Prothena with a reasonable opportunity to comment substantively on all material Program Regulatory Materials prior to filing or taking material action, and will reasonably and in good faith consider any comments and actions recommended by Prothena, including with respect to filing strategy. In addition, with respect to any Phase 1 Clinical Trial conducted by Celgene pursuant to Section 2.5, Celgene will allow Prothena or its representative to attend any and all meetings with Regulatory Authorities to the extent such attendance is not prohibited or limited by such Regulatory Authority. For clarity, if the Regulatory Transfer Date does not occur prior to the expiration of the Option Term for such Program, Section 2.6.1(a) (and not this Section 2.6.1(b)) shall apply.